The goal of pharmacovigilance is to spot, assess, comprehend, and avoid side effects or any other issues related to prescriptions. Because gene and cell therapies are novel treatments that may present unanticipated dangers to patient safety and public health, pharmacovigilance is crucial. ATMP developers are urged to make rapid appointments with EMA to guarantee a successful development process.